Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms

M. Ruella, Saad Kenderian, O. Shestova, M. Klichinsky, J. J. Melenhorst, M. A. Wasik, S. F. Lacey, C. H. June, S. Gill

Research output: Contribution to journalLetter

25 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)246-248
Number of pages3
JournalLeukemia
Volume31
Issue number1
DOIs
StatePublished - Jan 1 2017

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms. / Ruella, M.; Kenderian, Saad; Shestova, O.; Klichinsky, M.; Melenhorst, J. J.; Wasik, M. A.; Lacey, S. F.; June, C. H.; Gill, S.

In: Leukemia, Vol. 31, No. 1, 01.01.2017, p. 246-248.

Research output: Contribution to journalLetter

Ruella, M, Kenderian, S, Shestova, O, Klichinsky, M, Melenhorst, JJ, Wasik, MA, Lacey, SF, June, CH & Gill, S 2017, 'Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms', Leukemia, vol. 31, no. 1, pp. 246-248. https://doi.org/10.1038/leu.2016.262
Ruella, M. ; Kenderian, Saad ; Shestova, O. ; Klichinsky, M. ; Melenhorst, J. J. ; Wasik, M. A. ; Lacey, S. F. ; June, C. H. ; Gill, S. / Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms. In: Leukemia. 2017 ; Vol. 31, No. 1. pp. 246-248.
@article{f65da48716324cefbfb067671a323c0b,
title = "Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms",
author = "M. Ruella and Saad Kenderian and O. Shestova and M. Klichinsky and Melenhorst, {J. J.} and Wasik, {M. A.} and Lacey, {S. F.} and June, {C. H.} and S. Gill",
year = "2017",
month = "1",
day = "1",
doi = "10.1038/leu.2016.262",
language = "English (US)",
volume = "31",
pages = "246--248",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms

AU - Ruella, M.

AU - Kenderian, Saad

AU - Shestova, O.

AU - Klichinsky, M.

AU - Melenhorst, J. J.

AU - Wasik, M. A.

AU - Lacey, S. F.

AU - June, C. H.

AU - Gill, S.

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=84990878466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990878466&partnerID=8YFLogxK

U2 - 10.1038/leu.2016.262

DO - 10.1038/leu.2016.262

M3 - Letter

VL - 31

SP - 246

EP - 248

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 1

ER -